| - GRCh37:
- Chr17:17122397
- GRCh38:
- Chr17:17219083
| FLCN | S333*, S351* | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17122404-17122405
- GRCh38:
- Chr17:17219090-17219091
| FLCN | S331fs, S349fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17122473
- GRCh38:
- Chr17:17219159
| FLCN | E308*, E326* | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17122473
- GRCh38:
- Chr17:17219159
| FLCN | E308fs, E326fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17122488
- GRCh38:
- Chr17:17219174
| FLCN | E303*, E321* | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17122488-17122489
- GRCh38:
- Chr17:17219174-17219175
| FLCN | E303*, E321* | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17120433
- GRCh38:
- Chr17:17217119
| FLCN | W376R, W394R | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17122508
- GRCh38:
- Chr17:17219194
| FLCN | S296*, S314* | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17124863
- GRCh38:
- Chr17:17221549
| FLCN | E287*, E305* | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17124883-17124884
- GRCh38:
- Chr17:17221569-17221570
| FLCN | E280fs, E298fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17125821-17125824
- GRCh38:
- Chr17:17222507-17222510
| FLCN | S257fs, S275fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17131387
- GRCh38:
- Chr17:17228073
| FLCN | T22K | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17127248-17127249
- GRCh38:
- Chr17:17223934-17223935
| FLCN | K203fs, K221fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17127277-17127288
- GRCh38:
- Chr17:17223963-17223974
| FLCN | L189fs, L207fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17127415
- GRCh38:
- Chr17:17224101
| FLCN | Q147*, Q165* | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17127455-17127464
- GRCh38:
- Chr17:17224141-17224150
| FLCN | | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17127459
- GRCh38:
- Chr17:17224145
| FLCN | | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17120494-17120506
- GRCh38:
- Chr17:17217180-17217192
| FLCN | | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17127458
- GRCh38:
- Chr17:17224144
| FLCN | | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17127461-17127470
- GRCh38:
- Chr17:17224147-17224156
| FLCN | | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17127457-17127458
- GRCh38:
- Chr17:17224143-17224144
| FLCN | | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17129537-17129554
- GRCh38:
- Chr17:17226223-17226240
| FLCN | | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17129558
- GRCh38:
- Chr17:17226244
| FLCN | Q110* | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17129568
- GRCh38:
- Chr17:17226254
| FLCN | Y106* | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17131216
- GRCh38:
- Chr17:17227902
| FLCN | S79* | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17131267
- GRCh38:
- Chr17:17227953
| FLCN | S62fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17131272-17131273
- GRCh38:
- Chr17:17227958-17227959
| FLCN | H61fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17131259-17131284
- GRCh38:
- Chr17:17227945-17227970
| FLCN | S56fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17117043-17117044
- GRCh38:
- Chr17:17213729-17213730
| FLCN | G556fs, G574fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17117109-17117110
- GRCh38:
- Chr17:17213795-17213796
| FLCN | K534fs, K552fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17117119-17117120
- GRCh38:
- Chr17:17213805-17213806
| FLCN | D531fs, D549fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17131295-17131296
- GRCh38:
- Chr17:17227981-17227982
| FLCN | Q53fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17117147-17117153
- GRCh38:
- Chr17:17213833-17213839
| FLCN | F519fs, F537fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17117156
- GRCh38:
- Chr17:17213842
| FLCN | L518P, L536P | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17118298
- GRCh38:
- Chr17:17214984
| FLCN | | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17118325-17118326
- GRCh38:
- Chr17:17215011-17215012
| FLCN | L504fs, L522fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17118346-17118347
- GRCh38:
- Chr17:17215032-17215033
| FLCN | V497fs, V515fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17118541
- GRCh38:
- Chr17:17215227
| FLCN | E464*, E482* | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17119692
- GRCh38:
- Chr17:17216378
| FLCN | | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17119721
- GRCh38:
- Chr17:17216407
| FLCN | Q425*, Q443* | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17119766
- GRCh38:
- Chr17:17216452
| FLCN | E410*, E428* | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17131333
- GRCh38:
- Chr17:17228019
| FLCN | G40fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17122385-17122388
- GRCh38:
- Chr17:17219071-17219074
| FLCN | G336fs, G354fs | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| | FLCN | | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| | FLCN | | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| | FLCN | | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| | FLCN | | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| | FLCN | | Multiple fibrofolliculomas | Pathogenic (Jul 1, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17131252-17131253
- GRCh38:
- Chr17:17227938-17227939
| FLCN | A67fs | not provided | Pathogenic (Aug 15, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17124923-17124924
- GRCh38:
- Chr17:17221609-17221610
| FLCN | S267fs, S285fs | Multiple fibrofolliculomas | Pathogenic (Apr 10, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17122365-17122366
- GRCh38:
- Chr17:17219051-17219052
| FLCN | P344fs, P362fs | Multiple fibrofolliculomas | Pathogenic (Apr 6, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17125936
- GRCh38:
- Chr17:17222622
| FLCN | Q220*, Q238* | Hereditary cancer-predisposing syndrome | Pathogenic (Mar 29, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17127253
- GRCh38:
- Chr17:17223939
| FLCN | Q201*, Q219* | not provided | Pathogenic (Dec 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17124808
- GRCh38:
- Chr17:17221494
| FLCN | P305L | Multiple fibrofolliculomas | Uncertain significance (Mar 30, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17119280-17119281
- GRCh38:
- Chr17:17215966-17215967
| FLCN | | Multiple fibrofolliculomas | Pathogenic (Aug 4, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr17:17119707-17119708
- GRCh38:
- Chr17:17216393-17216394
| FLCN | H429fs, H447fs | Multiple fibrofolliculomas | Pathogenic (Jan 18, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17125922-17125923
- GRCh38:
- Chr17:17222608-17222609
| FLCN | T224fs, T242fs | Multiple fibrofolliculomas | Pathogenic (Jan 11, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17127226-17127467
| FLCN | | Multiple fibrofolliculomas | Pathogenic (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17118289-17140502
| FLCN | | Multiple fibrofolliculomas | Uncertain significance (Dec 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17135108-17135196
| FLCN | | Multiple fibrofolliculomas | Uncertain significance (Feb 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17116969-17120506
| FLCN | | Multiple fibrofolliculomas | Pathogenic (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17120504-17120505
- GRCh38:
- Chr17:17217190-17217191
| FLCN | | Multiple fibrofolliculomas | Likely benign (Jun 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17129551
- GRCh38:
- Chr17:17226237
| FLCN | P112L | Multiple fibrofolliculomas | Uncertain significance (Jan 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17122518
- GRCh38:
- Chr17:17219204
| FLCN | E293K, E311K | Multiple fibrofolliculomas | Uncertain significance (Apr 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17129641
- GRCh38:
- Chr17:17226327
| FLCN | | Multiple fibrofolliculomas | Likely benign (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17131195
- GRCh38:
- Chr17:17227881
| FLCN | | Multiple fibrofolliculomas | Likely benign (Feb 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17127281
- GRCh38:
- Chr17:17223967
| FLCN | | Multiple fibrofolliculomas | Likely benign (Jul 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17127278
- GRCh38:
- Chr17:17223964
| FLCN | | Multiple fibrofolliculomas | Likely benign (Mar 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17131222
- GRCh38:
- Chr17:17227908
| FLCN | K77R | Multiple fibrofolliculomas | Uncertain significance (Oct 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17118535
- GRCh38:
- Chr17:17215221
| FLCN | V466M, V484M | Multiple fibrofolliculomas | Uncertain significance (Oct 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17131190
- GRCh38:
- Chr17:17227876
| FLCN | | Multiple fibrofolliculomas | Likely benign (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17127317
- GRCh38:
- Chr17:17224003
| FLCN | | Multiple fibrofolliculomas | Likely benign (Jul 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17122513
- GRCh38:
- Chr17:17219199
| FLCN | E312D, E294D | Multiple fibrofolliculomas | Uncertain significance (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17120393
- GRCh38:
- Chr17:17217079
| FLCN | E389G, E407G | Multiple fibrofolliculomas | Uncertain significance (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17124849
- GRCh38:
- Chr17:17221535
| FLCN | | Multiple fibrofolliculomas | Likely pathogenic (May 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17118410-17118411
- GRCh38:
- Chr17:17215096-17215097
| FLCN | | Multiple fibrofolliculomas | Likely benign (Apr 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17131237
- GRCh38:
- Chr17:17227923
| FLCN | S72N | Multiple fibrofolliculomas | Uncertain significance (Sep 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17122500
- GRCh38:
- Chr17:17219186
| FLCN | W317G, W299G | Multiple fibrofolliculomas | Uncertain significance (May 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17125808
- GRCh38:
- Chr17:17222494
| FLCN | | Multiple fibrofolliculomas | Likely benign (Sep 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17127303
- GRCh38:
- Chr17:17223989
| FLCN | N184S, N202S | Multiple fibrofolliculomas | Uncertain significance (Jun 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17122462
- GRCh38:
- Chr17:17219148
| FLCN | | Multiple fibrofolliculomas | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17118527
- GRCh38:
- Chr17:17215213
| FLCN | | Multiple fibrofolliculomas | Uncertain significance (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17118575
- GRCh38:
- Chr17:17215261
| FLCN | | Multiple fibrofolliculomas | Likely benign (May 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17118617
- GRCh38:
- Chr17:17215303
| FLCN | | Multiple fibrofolliculomas | Uncertain significance (Jun 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17118415
- GRCh38:
- Chr17:17215101
| FLCN | | Multiple fibrofolliculomas | Likely benign (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17117018
- GRCh38:
- Chr17:17213704
| FLCN | H582P, H564P | Multiple fibrofolliculomas, Hereditary cancer-predisposing syndrome | Uncertain significance (Mar 5, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:17127231
- GRCh38:
- Chr17:17223917
| FLCN | | Multiple fibrofolliculomas | Uncertain significance (Jul 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17118423
- GRCh38:
- Chr17:17215109
| FLCN | | Multiple fibrofolliculomas | Likely benign (May 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17129597
- GRCh38:
- Chr17:17226283
| FLCN | S97G | Multiple fibrofolliculomas | Uncertain significance (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17120514
- GRCh38:
- Chr17:17217200
| FLCN | | Multiple fibrofolliculomas | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17127260
- GRCh38:
- Chr17:17223946
| FLCN | | Multiple fibrofolliculomas | Likely benign (Nov 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17118642
- GRCh38:
- Chr17:17215328
| FLCN | | Multiple fibrofolliculomas | Likely benign (Aug 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17122316
- GRCh38:
- Chr17:17219002
| FLCN | | Multiple fibrofolliculomas | Likely benign (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17119828
- GRCh38:
- Chr17:17216514
| FLCN | | Multiple fibrofolliculomas | Likely benign (Sep 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17127259
- GRCh38:
- Chr17:17223945
| FLCN | E199K, E217K | Multiple fibrofolliculomas, Hereditary cancer-predisposing syndrome | Uncertain significance (May 30, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:17122342
- GRCh38:
- Chr17:17219028
| FLCN | H369Q, H351Q | Multiple fibrofolliculomas | Uncertain significance (Feb 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17129634
- GRCh38:
- Chr17:17226320
| FLCN | C85fs | Multiple fibrofolliculomas, not provided | Pathogenic (Dec 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:17129563
- GRCh38:
- Chr17:17226249
| FLCN | S108I | Multiple fibrofolliculomas | Uncertain significance (May 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17127460
- GRCh38:
- Chr17:17224146
| FLCN | | Multiple fibrofolliculomas | Uncertain significance (May 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:17124898
- GRCh38:
- Chr17:17221584
| FLCN | E293G, E275G | Multiple fibrofolliculomas | Uncertain significance (May 5, 2022) | criteria provided, single submitter |